Xponance’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-10,297
| Closed | -$89.3K | – | 1349 |
|
|
2024
Q1 | $89.3K | Sell |
10,297
-706
| -6% | -$6.12K | ﹤0.01% | 1246 |
|
|
2023
Q4 | $72.1K | Buy |
11,003
+391
| +4% | +$2.56K | ﹤0.01% | 1223 |
|
|
2023
Q3 | $106K | Buy |
10,612
+88
| +0.8% | +$880 | ﹤0.01% | 1163 |
|
|
2023
Q2 | $131K | Sell |
10,524
-5,009
| -32% | -$62.3K | ﹤0.01% | 1178 |
|
|
2023
Q1 | $218K | Buy |
15,533
+1,070
| +7% | +$15K | ﹤0.01% | 1109 |
|
|
2022
Q4 | $207K | Buy |
14,463
+1,435
| +11% | +$20.5K | ﹤0.01% | 1116 |
|
|
2022
Q3 | $333K | Buy |
13,028
+190
| +1% | +$4.86K | 0.01% | 966 |
|
|
2022
Q2 | $365K | Buy |
12,838
+641
| +5% | +$18.2K | 0.01% | 960 |
|
|
2022
Q1 | $430K | Sell |
12,197
-540
| -4% | -$19K | 0.01% | 945 |
|
|
2021
Q4 | $534K | Buy |
12,737
+1,207
| +10% | +$50.6K | 0.01% | 875 |
|
|
2021
Q3 | $566K | Buy |
11,530
+2,922
| +34% | +$143K | 0.01% | 832 |
|
|
2021
Q2 | $359K | Buy |
+8,608
| New | +$359K | 0.01% | 1026 |
|